Evidence map›Paper›PMID 27392443›Full record

ArticleChild's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery2016

Pediatric thalamic glioma with H3F3A K27M mutation, which was detected before and after malignant transformation: a case report.

Kenichi Ishibashi, Takeshi Inoue, Hiroko Fukushima, Yusuke Watanabe, Yoshiyasu Iwai, Hiroaki Sakamoto, Kai Yamasaki, Jyunichi Hara, Tomoko Shofuda, Daiksuke Kanematsu and 2 more

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 45 citations in OpenAlex.

  1. Imaging features associated with H3 K27-altered and H3 G34-mutant gliomas: a narrative systematic review.Cancer imaging : the official publication of the International Cancer Imaging Society · 2022
    Pooled it
  2. Management of incidental brain tumors in children: a systematic review.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2020
    Pooled it
  3. Article
  4. Incidental brain tumor findings in children: prevalence, natural history, management, controversies, challenges, and dilemmas.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2024
    Review
  5. Article
  6. Article
  7. Indolent presentation of a diffuse midline glioma, H3 K27-altered.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2023
    Article
  8. Review
  9. Pediatric posterior fossa incidentalomas.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2020
    Article
  10. Malignant transformation of a conservatively managed incidental childhood cerebral mass lesion: controversy regarding management paradigm.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Kenichi IshibashiDepartment of Neurosurgery, Osaka City General Hospital, 2-13-22 Miyakojima hondori, Miyakojima-ku, Osaka, 534-0021, Japan. ishibashi@med.osaka-cu.ac.jp.
Takeshi InoueDepartment of Pathology, Osaka City General Hospital, 2-13-22 Miyakojima hondori, Miyakojima-ku, Osaka, 534-0021, Japan.
Hiroko FukushimaDepartment of Pathology, Osaka City General Hospital, 2-13-22 Miyakojima hondori, Miyakojima-ku, Osaka, 534-0021, Japan.
Yusuke WatanabeDepartment of Neurosurgery, Osaka City General Hospital, 2-13-22 Miyakojima hondori, Miyakojima-ku, Osaka, 534-0021, Japan.
Yoshiyasu IwaiDepartment of Neurosurgery, Osaka City General Hospital, 2-13-22 Miyakojima hondori, Miyakojima-ku, Osaka, 534-0021, Japan.
Hiroaki SakamotoDepartment of Pediatric Neurosurgery, Osaka City General Hospital, 2-13-22 Miyakojima hondori, Miyakojima-ku, Osaka, 534-0021, Japan.
Kai YamasakiDepartment of Pediatric Hematology/Oncology, Osaka City General Hospital, 2-13-22 Miyakojima hondori, Miyakojima-ku, Osaka, 534-0021, Japan.
Jyunichi HaraDepartment of Pediatric Hematology/Oncology, Osaka City General Hospital, 2-13-22 Miyakojima hondori, Miyakojima-ku, Osaka, 534-0021, Japan.
Tomoko ShofudaDivision of Stem Cell Research, Institute for Clinical Research, Osaka National Hospital, National Hospital Organization, 2-1-14 Hoenzaka, Chuo-ku, Osaka, 540-0006, Japan.
Daiksuke KanematsuDivision of Regenerative Medicine, Institute for Clinical Research, Osaka National Hospital, National Hospital Organization, 2-1-14 Hoenzaka, Chuo-ku, Osaka, 540-0006, Japan.
Ema YoshiokaDivision of Stem Cell Research, Institute for Clinical Research, Osaka National Hospital, National Hospital Organization, 2-1-14 Hoenzaka, Chuo-ku, Osaka, 540-0006, Japan.
Yonehiro KanemuraDivision of Regenerative Medicine, Institute for Clinical Research, Osaka National Hospital, National Hospital Organization, 2-1-14 Hoenzaka, Chuo-ku, Osaka, 540-0006, Japan.
Osaka City General Hospital · JPOsaka National Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeHistone H3.3 (H3F3A) mutation in the codon for lysine 27 (K27M) has been found as driver mutations in pediatric glioblastoma and has been suggested to play critical roles in the pathogenesis of thalamic gliomas and diffuse intrinsic pontine gliomas. We report a case of thalamic glioma with H3F3A K27M mutation, which was detected in both the primary tumor diagnosed as diffuse astrocytoma obtained during the first surgery and also in the tumor diagnosed as anaplastic astrocytoma obtained at the second surgery. CASE PRESENTATION: A 14-year-old girl presented with mild headache. Magnetic resonance imaging (MRI) showed a small intraaxial lesion in the left thalamus, which increased in size. Stereotactic tumor biopsy was performed 2 years after the initial diagnosis, and a pathological diagnosis of diffuse astrocytoma (WHO grade 2) was made. The tumor grew further and showed contrast enhancement on MRI despite 16 months of chemotherapy. Surgical removal via the transcallosal approach was then performed, and postoperative pathological diagnosis was anaplastic astrocytoma (WHO grade 3), indicating malignant transformation of the tumor. Molecular diagnosis of tumor tissue obtained at first and second surgeries revealed H3F3A K27M mutation in both primary and secondary specimens.

conclusionThis report demonstrates minute neuroradiological and pathological features of malignant transformation from thalamic low grade glioma with H3F3A K27M mutation. It is noteworthy that this mutation was found in this case when the tumor was still a low-grade glioma. Tissue sampling for genetic analysis is useful in patients with thalamic gliomas to predict the clinical course and efficacy of treatments.

Indexed as

AdolescentAstrocytomaBrain NeoplasmsCell Transformation, NeoplasticFemaleHistonesHumansMutationThalamusH3-3A protein, humanHistonesH3F3A K27M mutationMalignant transformationThalamic gliomas

Identifiers

PMID27392443
OpenAlexW2464395241

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.